Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Total Current Liabilities (2019 - 2025)

Cresco Labs' Total Current Liabilities history spans 7 years, with the latest figure at $100.2 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 6.19% year-over-year to $100.2 million; the TTM value through Dec 2025 reached $100.2 million, up 6.19%, while the annual FY2025 figure was $100.2 million, 6.19% up from the prior year.
  • Total Current Liabilities reached $100.2 million in Q4 2025 per CRLBF's latest filing, up from $94.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $288.4 million in Q4 2021 to a low of $94.3 million in Q4 2024.
  • Average Total Current Liabilities over 5 years is $187.8 million, with a median of $200.2 million recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: increased 14.06% in 2021, then tumbled 52.89% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $288.4 million in 2021, then dropped by 11.28% to $255.9 million in 2022, then decreased by 21.74% to $200.2 million in 2023, then crashed by 52.89% to $94.3 million in 2024, then increased by 6.19% to $100.2 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Total Current Liabilities are $100.2 million (Q4 2025), $94.3 million (Q4 2024), and $200.2 million (Q4 2023).